旭輝控股集團(00884.HK)獲控股股東增持50萬股
格隆匯9月19日丨旭輝控股集團(00884.HK)公佈,公司董事會已獲公司執行董事及控股股東林中、林偉及林峯(統稱"控股股東")吿知,彼等於公吿日期透過聯繫人在公開市場購買合共50萬股公司股份,總代價約為82.5萬港元(不包括相關交易費)。緊隨上述購買後,控股股東於合共4,870,743,385股股份中擁有權益,相當於截至公吿日期的已發行股份總數約51.55%。
控股股東對公司的未來前景充滿信心,並可能考慮日後於適當時候進一步增持彼等於公司的股權,惟須遵守適用法律及監管規定。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.